{{ languageVal }}
  • English
 

Industry Updates

The Regulatory 15/15: November 2020

15 Nov 2020

The Regulatory 15/15 is a monthly regulatory webcast released on the 15th day of each month and lasts for 15 minutes. In this webcast, Chris Capewell, head of our Regulatory team, will be joined by fellow partners Tim Dawson and Pat Head.

This month's Regulatory 15/15 webcast will cover the following topics:

•    DITC Update
•    Economic Substance Update
•    VASP 
•    Proposed Threshold Reporting for Banks 
•    Imposition of CIMA Administrative Fine
•    Monthly New Product (MNP) - Maples Group provides accounting, tax and agency services

To listen, please click the below. Note that this webcast is available worldwide and On Demand.

Listen here

Visit our Webcast Engagement Hub for more content.

Related Services

Dispute Resolution & Insolvency

Advising on the laws of BVI, the Cayman Islands and Ireland, our global Dispute Resolution & Insolvency team provides expert legal advice on cross-border litigation and contentious and non-contentious restructuring.  We offer a broad range of dispute resolution and insolvency services, bringing an unrivalled depth of experience to each dispute and ensuring that you receive fast, accurate and pragmatic advice. 

Regulatory

Our global Regulatory & Compliance group has unrivalled experience in the regulatory, disclosure, enforcement and AML fields. Providing legal advice on the laws of the BVI, the Cayman Islands and Ireland, our team will competently, efficiently and sensitively handle your commercial reputation and viability in relation to risk management and regulatory compliance

Regulatory & Financial Services Advisory 

Our global team of regulatory lawyers provides expert legal advice to BVI, Cayman Islands, Irish, Jersey and Luxembourg entities regarding AML and CTF compliance including development and assessment of AML / CTF and risk management systems, KYC and customer due diligence best practices, conduct of money laundering and fraud proceedings and provision of expert evidence on AML / CTF and regulatory obligations.